PRODUCT DETAIL

Ezetimib/simvastatín Teva B.V. 10 mg/40 mg

Code

1630C

MA number

31/0476/16-S

Product Form:

tbl 100x10 mg/40 mg (obal HDPE)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

Mutual recognition procedure

MAH, country:

Teva B.V., Netherland

Therapeutic Class:

31 - HYPOLIPIDAEMICA

ATC:

C	CARDIOVASCULAR SYSTEM
C10	Lipid modifying agents
C10B	Lipid modifying agents, combinations
C10BA	Combinations of various lipid modifying agents
C10BA02	Simvastatin and ezetimibe

Shelf life:

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	14.11.2016
Pediatric posology:	Yes
Pediatric warnings:	Yes
PIL:	PIL_Ezetimib-simvastatín Teva B.V._05.2023.pdf
SPC:	SPC_Ezetimib-simvastatín Teva B.V._05.2023.pdf
Safety feature	Yes
Data update:	23.09.2019